TAS2R4
geneOn this page
Also known as T2R4
Summary
TAS2R4 (taste 2 receptor member 4, HGNC:14911) is a protein-coding gene on chromosome 7q34, encoding Taste receptor type 2 member 4 (Q9NYW5). Gustducin-coupled receptor for denatonium and N(6)-propyl-2-thiouracil implicated in the perception of bitter compounds in the oral cavity and the gastrointestinal tract.
This gene encodes a member of a family of candidate taste receptors that are members of the G protein-coupled receptor superfamily and that are specifically expressed by taste receptor cells of the tongue and palate epithelia. These apparently intronless genes encode a 7-transmembrane receptor protein, functioning as a bitter taste receptor. This gene is clustered with another 3 candidate taste receptor genes in chromosome 7 and is genetically linked to loci that influence bitter perception.
Source: NCBI Gene 50832 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 48 total
- Druggable target: yes — 1 molecules with ChEMBL bioactivity
- MANE Select transcript:
NM_016944
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14911 |
| Approved symbol | TAS2R4 |
| Name | taste 2 receptor member 4 |
| Location | 7q34 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | T2R4 |
| Ensembl gene | ENSG00000127364 |
| Ensembl biotype | protein_coding |
| OMIM | 604869 |
| Entrez | 50832 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000247881
RefSeq mRNA: 1 — MANE Select: NM_016944
NM_016944
CCDS: CCDS5868
Canonical transcript exons
ENST00000247881 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000872186 | 141776674 | 141781691 |
Expression profiles
Bgee: expression breadth ubiquitous, 160 present calls, max score 84.11.
Top tissues by expression
286 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.11 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.18 | silver quality |
| sural nerve | UBERON:0015488 | 73.71 | gold quality |
| buccal mucosa cell | CL:0002336 | 70.22 | silver quality |
| cerebellar hemisphere | UBERON:0002245 | 68.36 | gold quality |
| cerebellar cortex | UBERON:0002129 | 68.32 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 68.16 | gold quality |
| cerebellum | UBERON:0002037 | 65.91 | gold quality |
| tibialis anterior | UBERON:0001385 | 65.03 | silver quality |
| colonic epithelium | UBERON:0000397 | 64.43 | silver quality |
| right uterine tube | UBERON:0001302 | 63.65 | gold quality |
| cortical plate | UBERON:0005343 | 62.87 | gold quality |
| mucosa of urinary bladder | UBERON:0001259 | 62.14 | gold quality |
| nucleus accumbens | UBERON:0001882 | 60.44 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 59.53 | gold quality |
| calcaneal tendon | UBERON:0003701 | 59.34 | gold quality |
| prefrontal cortex | UBERON:0000451 | 59.28 | gold quality |
| right ovary | UBERON:0002118 | 58.94 | gold quality |
| ventricular zone | UBERON:0003053 | 58.67 | silver quality |
| right frontal lobe | UBERON:0002810 | 58.46 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 58.20 | gold quality |
| cingulate cortex | UBERON:0003027 | 58.17 | gold quality |
| caudate nucleus | UBERON:0001873 | 58.05 | gold quality |
| left ovary | UBERON:0002119 | 57.95 | gold quality |
| putamen | UBERON:0001874 | 57.53 | gold quality |
| ganglionic eminence | UBERON:0004023 | 57.25 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 56.73 | gold quality |
| body of uterus | UBERON:0009853 | 56.68 | gold quality |
| body of pancreas | UBERON:0001150 | 56.50 | gold quality |
| tibial nerve | UBERON:0001323 | 56.23 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.71 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 12)
- This study demonistrated that human TAS2R4 play the role of food preference behavior. (PMID:22794107)
- these results show that rhodopsin N-terminal 33 amino acids enhance expression of T2R4 by 2.5-fold and do not cause perturbations in the receptor structure. (PMID:23159609)
- Data indicate that the itter blockers and agonists share the same orthosteric site in bitter taste receptor T2R4. (PMID:25059668)
- The antagonist ability of ABA was tested using another T2R4 agonist, yohimbine. Our results suggest that ABA does not inhibit yohimbine-induced T2R4 activity. (PMID:25844797)
- Data indicate that KLK/R motif in C-terminus performs functional role in bitter taste receptor T2R4 signaling. (PMID:25858111)
- demonstrate that Lys117, an important CRAC residue, is crucial in the reported cholesterol sensitivity of T2R4. Interestingly, cholesterol sensitivity of T2R4 was observed at quinine concentrations in the lower mM range. (PMID:27288892)
- This study is the first to show an inhibitory downstream action of a T2R4 agonist on Rac1 function. (PMID:27873143)
- In summary, genetic variations in T2R3/4 bitterness receptors may modify the papillary thyroid carcinoma (PTC) risk, and the genetically modified thyroid hormone level by those variations may be linked with the PTC-T2Rs association (PMID:30301923)
- Chemosensory bitter taste receptors T2R4 and T2R14 activation attenuates proliferation and migration of breast cancer cells. (PMID:31894529)
- Bitter receptor member TAS2R4 may have neurobiological function beyond acting as a bitter receptor. (PMID:32159211)
- Genetic Variation in the Bitter Receptors Responsible for Epicatechin Detection Are Associated with BMI in an Elderly Cohort. (PMID:33572225)
- Differential Activation of TAS2R4 May Recover Ability to Taste Propylthiouracil for Some TAS2R38 AVI Homozygotes. (PMID:38732607)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tas2r200.2 | ENSDARG00000074066 |
| danio_rerio | tas2r200.1 | ENSDARG00000079880 |
| mus_musculus | Tas2r108 | ENSMUSG00000037140 |
| rattus_norvegicus | Tas2r108 | ENSRNOG00000012195 |
Paralogs (23): TAS2R8 (ENSG00000121314), TAS2R10 (ENSG00000121318), TAS2R7 (ENSG00000121377), TAS2R9 (ENSG00000121381), TAS2R3 (ENSG00000127362), TAS2R5 (ENSG00000127366), TAS2R16 (ENSG00000128519), TAS2R1 (ENSG00000169777), TAS2R60 (ENSG00000185899), TAS2R42 (ENSG00000186136), TAS2R19 (ENSG00000212124), TAS2R50 (ENSG00000212126), TAS2R14 (ENSG00000212127), TAS2R13 (ENSG00000212128), TAS2R41 (ENSG00000221855), TAS2R40 (ENSG00000221937), TAS2R46 (ENSG00000226761), TAS2R39 (ENSG00000236398), TAS2R43 (ENSG00000255374), TAS2R20 (ENSG00000255837), TAS2R30 (ENSG00000256188), TAS2R31 (ENSG00000256436), TAS2R38 (ENSG00000257138)
Protein
Protein identifiers
Taste receptor type 2 member 4 — Q9NYW5 (reviewed: Q9NYW5)
All UniProt accessions (1): Q9NYW5
UniProt curated annotations — full annotation on UniProt →
Function. Gustducin-coupled receptor for denatonium and N(6)-propyl-2-thiouracil implicated in the perception of bitter compounds in the oral cavity and the gastrointestinal tract. Signals through PLCB2 and the calcium-regulated cation channel TRPM5. In airway epithelial cells, binding of denatonium increases the intracellular calcium ion concentration and stimulates ciliary beat frequency.
Subcellular location. Membrane. Cell projection. Cilium membrane.
Tissue specificity. Expressed in subsets of taste receptor cells of the tongue and palate epithelium and exclusively in gustducin-positive cells. Expressed on airway ciliated epithelium.
Miscellaneous. Several bitter taste receptors are expressed in a single taste receptor cell.
Similarity. Belongs to the G-protein coupled receptor T2R family.
RefSeq proteins (1): NP_058640* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007960 | TAS2R | Family |
| IPR030055 | TAS2R4 | Family |
Pfam: PF05296
UniProt features (26 total): topological domain 8, transmembrane region 7, sequence variant 7, glycosylation site 3, chain 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9M8K | ELECTRON MICROSCOPY | 3 |
| 9M8L | ELECTRON MICROSCOPY | 3.3 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NYW5-F1 | 84.64 | 0.47 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (3): 164, 165, 169
Function
Pathways and Gene Ontology
Reactome pathways
9 pathways
| ID | Pathway |
|---|---|
| R-HSA-418594 | G alpha (i) signalling events |
| R-HSA-420499 | Class C/3 (Metabotropic glutamate/pheromone receptors) |
| R-HSA-9717207 | Sensory perception of sweet, bitter, and umami (glutamate) taste |
| R-HSA-162582 | Signal Transduction |
| R-HSA-372790 | Signaling by GPCR |
| R-HSA-388396 | GPCR downstream signalling |
| R-HSA-500792 | GPCR ligand binding |
| R-HSA-9709957 | Sensory Perception |
| R-HSA-9717189 | Sensory perception of taste |
MSigDB gene sets: 54 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE, GOBP_SENSORY_PERCEPTION_OF_TASTE, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, OCT1_B, GOCC_CELL_PROJECTION_MEMBRANE, GOCC_PLASMA_MEMBRANE_REGION, GOCC_CILIARY_MEMBRANE, GOCC_CILIUM, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_BITTER_TASTE_RECEPTOR_ACTIVITY, GOMF_TASTE_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
GO Biological Process (5): detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580), respiratory gaseous exchange by respiratory system (GO:0007585), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of taste (GO:0050909)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), taste receptor activity (GO:0008527), bitter taste receptor activity (GO:0033038)
GO Cellular Component (5): plasma membrane (GO:0005886), membrane (GO:0016020), ciliary membrane (GO:0060170), cilium (GO:0005929), cell projection (GO:0042995)
Reactome top-level categories
Rollup of top-6 pathways:
| Category | Pathways |
|---|---|
| Signaling by GPCR | 2 |
| GPCR downstream signalling | 1 |
| GPCR ligand binding | 1 |
| Sensory perception of taste | 1 |
| Signal Transduction | 1 |
| Sensory Perception | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| detection of chemical stimulus involved in sensory perception of taste | 2 |
| transmembrane signaling receptor activity | 2 |
| cellular anatomical structure | 2 |
| sensory perception of bitter taste | 1 |
| multicellular organismal process | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of bitter taste | 1 |
| taste receptor activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cilium | 1 |
| cell projection membrane | 1 |
| bounding membrane of organelle | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
Protein interactions and networks
STRING
402 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TAS2R4 | GNAT3 | A8MTJ3 | 918 |
| TAS2R4 | PLCB2 | Q00722 | 888 |
| TAS2R4 | TAS1R2 | Q8TE23 | 820 |
| TAS2R4 | TAS1R3 | Q7RTX0 | 816 |
| TAS2R4 | TRPM5 | Q9NZQ8 | 641 |
| TAS2R4 | TULP3 | O75386 | 547 |
| TAS2R4 | TAS1R1 | Q7RTX1 | 540 |
| TAS2R4 | SLC5A1 | P13866 | 511 |
| TAS2R4 | OPRD1 | P41143 | 483 |
| TAS2R4 | TAS2R3 | Q9NYW6 | 479 |
| TAS2R4 | OR10A4 | Q9H209 | 478 |
| TAS2R4 | OR5K3 | A6NET4 | 460 |
| TAS2R4 | SSTR3 | P32745 | 453 |
| TAS2R4 | OR51A7 | Q8NH64 | 451 |
| TAS2R4 | OR52E8 | Q6IFG1 | 447 |
IntAct
0 interactions, top by confidence:
BioGRID (1): TAS2R4 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: P04201, P12526, P23749, P30554, P35410, P59534, P59535, Q3KNA1, Q3UG50, Q3UG61, Q4VHE7, Q645S5, Q645U4, Q645Y7, Q645Y8, Q645Y9, Q646A9, Q646B0, Q646C8, Q646D3, Q646F0, Q646F1, Q67ER9, Q67ES7, Q67ET0, Q67ET2, Q7TN38, Q7TN41, Q7TN44, Q7TN51, Q7TQA5, Q7TQA6, Q7TQB8, Q8CIP3, Q8R4G1, Q8TDS7, Q8VCJ6, Q91WW2, Q91WW3, Q91ZB8
Diamond homologs: P59530, P59532, P59534, P59536, P59537, P59539, P59540, P59541, P59551, Q2AB83, Q50KZ9, Q5Y4Y8, Q5Y4Z0, Q5Y4Z8, Q5Y500, Q645S2, Q645S5, Q645T0, Q645T4, Q645T7, Q645U1, Q645U2, Q645U4, Q645U6, Q645U7, Q645U8, Q645V1, Q645V3, Q645V8, Q645V9, Q645Y3, Q645Y4, Q645Y5, Q645Y7, Q645Y8, Q645Z0, Q645Z5, Q645Z7, Q646A2, Q646A3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
48 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 37 |
| Likely benign | 9 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
194 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:141780609:GCACA:G | acceptor_gain | 0.9600 |
| 7:141780608:A:AG | acceptor_gain | 0.9200 |
| 7:141780609:G:GG | acceptor_gain | 0.9200 |
| 7:141778479:A:AG | donor_gain | 0.8400 |
| 7:141778483:G:GG | donor_gain | 0.7800 |
| 7:141778479:A:G | donor_gain | 0.7400 |
| 7:141778482:A:AG | donor_gain | 0.7400 |
| 7:141778712:A:T | donor_gain | 0.6900 |
| 7:141779085:A:AG | acceptor_gain | 0.6900 |
| 7:141779163:T:G | donor_gain | 0.6500 |
| 7:141780604:A:C | acceptor_gain | 0.6300 |
| 7:141780595:TACA:T | acceptor_gain | 0.5600 |
| 7:141780597:C:G | acceptor_gain | 0.5500 |
| 7:141780610:C:G | acceptor_gain | 0.5400 |
| 7:141780598:A:T | acceptor_gain | 0.5200 |
| 7:141778481:GA:G | donor_gain | 0.5100 |
| 7:141779090:A:AG | acceptor_gain | 0.5100 |
| 7:141778718:C:A | donor_gain | 0.5000 |
| 7:141779089:C:G | acceptor_gain | 0.5000 |
| 7:141780594:A:T | acceptor_gain | 0.4800 |
| 7:141779171:C:CG | donor_gain | 0.4700 |
| 7:141780605:CACAG:C | acceptor_gain | 0.4700 |
| 7:141780609:GCAC:G | acceptor_gain | 0.4700 |
| 7:141779164:G:GG | donor_gain | 0.4500 |
| 7:141780498:A:T | acceptor_gain | 0.4500 |
| 7:141780596:A:T | acceptor_gain | 0.4500 |
| 7:141779155:G:GT | donor_gain | 0.4400 |
| 7:141778486:AAGAT:A | donor_gain | 0.4300 |
| 7:141778500:A:AG | donor_gain | 0.4300 |
| 7:141780503:A:T | acceptor_gain | 0.4300 |
AlphaMissense
1949 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:141778771:A:C | S95R | 0.953 |
| 7:141778773:T:A | S95R | 0.953 |
| 7:141778773:T:G | S95R | 0.953 |
| 7:141778546:G:A | G20R | 0.950 |
| 7:141778546:G:C | G20R | 0.950 |
| 7:141779064:T:A | N192K | 0.950 |
| 7:141779064:T:G | N192K | 0.950 |
| 7:141778560:T:A | N24K | 0.949 |
| 7:141778560:T:G | N24K | 0.949 |
| 7:141778636:A:C | S50R | 0.945 |
| 7:141778638:C:A | S50R | 0.945 |
| 7:141778638:C:G | S50R | 0.945 |
| 7:141778854:G:C | K122N | 0.945 |
| 7:141778854:G:T | K122N | 0.945 |
| 7:141779191:T:C | F235L | 0.934 |
| 7:141779193:C:A | F235L | 0.934 |
| 7:141779193:C:G | F235L | 0.934 |
| 7:141778840:T:C | F118L | 0.930 |
| 7:141778842:T:A | F118L | 0.930 |
| 7:141778842:T:G | F118L | 0.930 |
| 7:141779096:T:C | L203S | 0.928 |
| 7:141778894:T:C | C136R | 0.926 |
| 7:141778768:A:C | S94R | 0.925 |
| 7:141778770:C:A | S94R | 0.925 |
| 7:141778770:C:G | S94R | 0.925 |
| 7:141778666:G:A | G60R | 0.924 |
| 7:141778666:G:C | G60R | 0.924 |
| 7:141778797:T:A | N103K | 0.923 |
| 7:141778797:T:G | N103K | 0.923 |
| 7:141778777:T:A | W97R | 0.922 |
dbSNP variants (sampled 300 via entrez): RS1000367134 (7:141777657 A>G), RS1000400104 (7:141782090 T>C), RS1000419230 (7:141778000 A>G), RS1000781380 (7:141777781 A>G), RS1001548850 (7:141778131 C>G,T), RS1001996581 (7:141778388 G>A), RS1002079323 (7:141778345 T>TCATGAATGGCA), RS1002612498 (7:141779773 G>A), RS1003562300 (7:141780601 T>C,G), RS1003742180 (7:141779691 A>G), RS1004022577 (7:141780823 A>G,T), RS1005118715 (7:141774919 C>T), RS1005321190 (7:141781456 A>C), RS1005422620 (7:141775923 C>G), RS1005453641 (7:141776060 T>C)
Disease associations
OMIM: gene MIM:604869 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001961_2 | Anorexia nervosa | 2.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL3309107 (SINGLE PROTEIN)
Molecules with ChEMBL bioactivity
1 molecules (phase ≥1), by development phase (incl. off-target/promiscuous compounds). Patent mentions across the top 20 by phase: 40,234 (via chembl_molecule»patent_compound — counts attach to the compound, not the gene–compound relationship, so off-target/promiscuous molecules can dominate).
| Molecule | Name | Phase | Patents |
|---|---|---|---|
| CHEMBL434 | ISOPROTERENOL | 4 | 40,234 |
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Taste 2 receptors
Most potent curated ligand interactions (5 total), top 5:
| Ligand | Action | Affinity | Parameter |
|---|---|---|---|
| L-Trp-Trp-Trp | Agonist | 4.52 | pEC50 |
| abscisic acid | Antagonist | 4.46 | pIC50 |
| azithromycin | Agonist | 4.13 | pEC50 |
| stevioside | Agonist | 3.47 | pEC50 |
| colchicine | Agonist | 2.99 | pEC50 |
ChEMBL bioactivities
1 potent at pChembl≥5 of 1 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 8.31 | EC50 | 4.9 | nM | ISOPROTERENOL |
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases expression, increases mutagenesis | 2 |
| Tobacco Smoke Pollution | increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | decreases expression | 1 |
| potassium chromate(VI) | increases expression, affects cotreatment | 1 |
| epigallocatechin gallate | affects cotreatment, increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| Hydrogen Peroxide | decreases expression | 1 |
| Tetrachlorodibenzodioxin | increases expression | 1 |
| Thiram | increases expression | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Lactic Acid | increases expression | 1 |
| Permethrin | increases expression | 1 |
ChEMBL screening assays
8 unique, capped per target: 7 functional, 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL3361956 | Binding | Agonist activity at human TAS2R4 expressed in U2OS cells by Ga16gust44 Clone 2B FLIPR/summary (Abse5) assay | Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120). — Bioorg Med Chem Lett |
| CHEMBL4346424 | Functional | Antagonist activity at recombinant human TAS2R4 transiently expressed in HEK293T co-expressing Galpha16gust44 assessed as inhibition of chloroquine-induced intracellular calcium level by measuring remaining activity at 25 uM by fluo-4AM dye | Discovery and Development of S6821 and S7958 as Potent TAS2R8 Antagonists. — J Med Chem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Targeted by drugs: Azithromycin, Colchicine
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): anorexia nervosa